Biphasic insulin aspart 30 (BIAsp 30) in clinical reality: Experience from a Dutch practice

被引：0
|
作者：
Ligthelm, Robert J.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A540 / A540
页数：1
相关论文
共 50 条
  • [21] Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial
    McCrimmon, Rory J.
    Home, Philip
    Cheng, Alice
    Giorgino, Francesco
    Fonseca, Vivian
    Souhami, Elisabeth
    Alvarez, Agustina
    Picard, Pascaline
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2022, 24 (12): : 2391 - 2399
  • [22] Biphasic insulin aspart 30 (BIAsp30), insulin detemir (IDet) and insulin aspart (IAsp) allow patients with type 2 diabetes to reach A1C target: The PRIEFER study
    Liebl, Andreas
    Prager, Rudolf
    Kaiser, Marcel
    Binz, Katharina
    Gallwitz, Baptist
    DIABETES, 2006, 55 : A123 - A123
  • [23] Examining patient outcomes following different regimens of biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) in the large, multinational, IMPROVE™ observational study
    Ligthelm, R. J.
    Valensi, P.
    van der Lubbe, W.
    DIABETOLOGIA, 2009, 52 : S94 - S94
  • [24] 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
    Liebl, Andreas
    Mohan, Viswanathan
    Yang, Wenying
    Strojek, Krzysztof
    Linjawi, Sultan
    DRUGS IN R&D, 2018, 18 (01) : 27 - 39
  • [25] 15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
    Andreas Liebl
    Viswanathan Mohan
    Wenying Yang
    Krzysztof Strojek
    Sultan Linjawi
    Drugs in R&D, 2018, 18 : 27 - 39
  • [26] Patients with Type 2 diabetes mellitus have lower rates of nocturnal hypoglycaemia on biphasic insulin aspart (BIAsp30) than on biphasic human insulin-30 (BHI30): data from the REACH study
    McNally, PG
    Nelson, G
    Fitch, M
    DIABETOLOGIA, 2004, 47 : A327 - A327
  • [27] Improved Safety and Efficacy Profile in Patients with Type 2 Diabetes Treated with Biphasic Insulin Aspart 30 (BIAsp 30): Iran Subgroup of the IMPROVE Study
    Esteghamati, Alireza
    Rajabian, Reza
    Amini, Masoud
    Bahrami, Amir
    Khamseh, Mohammad Ebrahim
    Ardekani, Mohammad Afkhami
    Rizi, Ehsan Parvaresh
    DIABETES, 2009, 58 : A527 - A527
  • [28] Patient treatment satisfaction before starting biphasic insulin aspart (BIAsp 30):: EMPROVE™ study data from China, Japan and Poland
    Gumprecht, Janusz
    Wenying, Yang
    Valensi, Paul
    Christensen, Torsten
    Borzi, Vito
    DIABETES, 2007, 56 : A506 - A506
  • [29] Safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes mellitus in the Pakistani population: Results from the A1chieve study
    Hassan, Mohammad Imtiaz
    Aamir, Azizul Hasan
    Miyan, Zahid
    Siddiqui, Laiq Ahmed
    Qureshi, Muhammad Saleem
    Shaikh, Muhammad Zaman
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (09) : 929 - 936
  • [30] Improved glycaemic control in over 11,000 elderly patients from the IMPROVE™ Study of biphasic insulin aspart 30/70 (BIAsp 30) in eight countries
    Borzi, V.
    Shah, S.
    Knudsen, V. K.
    DIABETOLOGIA, 2009, 52 : S348 - S348
12345